Section Arrow
Quote
CLSD.NASDAQ
- Clearside Biomedical Inc
(Financial Status)
Quotes are at least 15-min delayed:2025/11/16 06:44 EST
Regular Hours
Last
 3.82
+0.13 (+3.52%)
Day High 
4 
Prev. Close
3.69 
1-M High
4.26 
Volume 
44.09K 
Bid
3.57
Ask
4.11
Day Low
3.6 
Open
3.65 
1-M Low
3.6 
Market Cap 
19.31M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 3.87 
20-SMA 3.86 
50-SMA 4.09 
52-W High 17.1 
52-W Low 3.32 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.40/-2.63
Enterprise Value
19.64M
Balance Sheet
Book Value Per Share
-9.31
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.66M
Operating Revenue Per Share
0.31
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1063+0.0011+1.05%-- 
CYPHCypherpunk Technologies Inc.2.75+0.99+56.25%-- 
IVVDInvivyd2.35+0.58+32.77%-- 
APLTApplied Therapeutics0.2183-0.0517-19.15%-- 
RXRXRecursion Pharmaceuticals4.14-0.19-4.39%-- 
Quotes are at least 15-min delayed：2025/11/16 06:44 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.